Writing in the Global Health Governance blog, research intern Courtney Page examines the future of global health financing, highlighting the launch of the Global Health Investment Fund (GHIF) by JPMorgan Chase & Co. and the Bill & Melinda Gates Foundation last month, which she states “is the first to allow individuals and institutions the opportunity to finance late-stage research and development of high-impact technologies and vaccinations that have the potential to save millions, with the potential earnings for investors.” She describes how the new fund works, and writes, “It has provided a new and creative way to bring innovation solutions and effective treatments into the global marketplace to make our society stronger and healthier; it has attracted an entirely new stream of revenue that would have been invested elsewhere, but can now be invested in the healthy futures of individuals, communities, and nations around the world” (10/21).